Unbound MEDLINE

Heat-shock protein 70 from plant biofactories of recombinant antigens activate multiepitope-targeted immune responses.

Abstract

Although a physiological role of heat-shock proteins (HSP) in antigen presentation and immune response activation has not been directly demonstrated, their use as vaccine components is under clinical trial. We have previously demonstrated that the structure of plant-derived HSP70 (pHSP70) can be superimposed to the mammalian homologue and similarly to the mammalian counterpart, pHSP70-polypeptide complexes can activate the immune system. It is here shown that pHSP70 purified from plant tissues transiently expressing the influenza virus nucleoprotein are able to induce both the activation of major histocompatibility complex class I-restricted polyclonal T-cell responses and antibody production in mice of different haplotypes without the need of adjuvant co-delivery. These results indicate that pHSP70 derived from plants producing recombinant antigens may be used to formulate multiepitope vaccines.

Links

  • Publisher Full Text
  • Authors

    Buriani G, Mancini C, Benvenuto E, Baschieri S

    Institution

    Laboratorio Biotecnologie Unità Tecnica BIORAD, ENEA C.R. Casaccia, Roma, Italy.

    Source

    Plant biotechnology journal 10:3 2012 Apr pg 363-71

    MeSH

    Agrobacterium tumefaciens
    Animals
    Antibody Formation
    Enzyme-Linked Immunospot Assay
    Escherichia coli
    Female
    Genetic Vectors
    HSP70 Heat-Shock Proteins
    Histocompatibility Antigens Class I
    Immunodominant Epitopes
    Influenza A Virus, H1N1 Subtype
    Lymphocyte Activation
    Mice
    Mice, Inbred BALB C
    Mice, Inbred C57BL
    Plant Leaves
    RNA-Binding Proteins
    Recombinant Proteins
    Tobacco
    Viral Core Proteins

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22221920